Armata Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ARMP for the last quarter is 1.53 M USD, and it's 24.73% higher compared to the previous quarter. The net income of Q4 23 is -19.85 M USD.